CPZ and acute myeloid leukemia: In addition, because anti-AML activities of CPZ were mainly mediated by altering the location of MT-RTKs, our result suggests that blocking compartment-dependent oncogenic signaling of MT-RTKs would be a therapeutic strategy for AML with MT-RTKs.